Ignite Creation Date:
2025-12-24 @ 2:46 PM
Ignite Modification Date:
2025-12-28 @ 9:02 AM
Study NCT ID:
NCT01721759
Status:
COMPLETED
Last Update Posted:
2022-06-28
First Post:
2012-11-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-11-16
Start Date Type:
ACTUAL
Primary Completion Date:
2014-01-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-04-22
Completion Date Type:
ACTUAL
First Submit Date:
2012-11-02
First Submit QC Date:
None
Study First Post Date:
2012-11-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-09-14
Results First Submit QC Date:
None
Results First Post Date:
2015-10-22
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2015-03-26
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2022-06-03
Last Update Post Date:
2022-06-28
Last Update Post Date Type:
ACTUAL